Product Disclaimer Manufactured in a GMP-compliant ISO 9001:2008 facility and guaranteed 99% purity
doi: 10.1038/srep19076, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 153
Clin Neurol Neurosurg 1(195):105878 Wade AG, Farmer M, Harari G, Fund N, Laudon M, Nir T, Frydman-Marom A, Zisapel N (2014) Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimers disease: a 6-month, randomized, placebo-controlled, multicenter trial
Disclosures: Rambabu Surabattula: Nothing to Disclose, Valentina Strohmeier: Nothing to Disclose, Anna-Maria Globig: Nothing to Disclose, Sudha Myneni: Nothing to Disclose, Maximilian Heeg: Nothing to Disclose, Gerhard Kindle: Nothing to Disclose, Sigune Goldacker: Nothing to Disclose, Caroline von Spee-Mayer: Nothing to Disclose, Michele Proietti: Nothing to Disclose, Birke Bausch: Nothing to Disclose, Dominik Bettinger: Nothing to Disclose, Michael Schulthei: Nothing to Disclose, Robert Thimme: Nothing to Disclose, Klaus Warnatz: Nothing to Disclose, Detlef Schuppan: Nothing to Disclose 2040 LOXL1 G153D MUTATION IS ASSOCIATED WITH NON-REGRESSION OF LIVER FIBROSIS DURING VIRAL CLEARANCE IN CHRONIC HBV INFECTION Wen Zhang 1 Wei Chen 1 Yameng Sun 1 Ning Zhang 1 Hong Li 1 Wenyue Wu 1 Xiaoning Wu 1 Xuzhen Yan 1 Qi Han 1 Aiting Yang 1 Hong You 1 , 1 Beijing Friendship Hospital, Capital Medical University Background: Lysyl oxidase like-1 (LOXL1), a member of the lysyl oxidase family, is responsible for cross-linking and stabilizing extracellular matrix (ECM) structural proteins
(2015) Effect of water-miscible organic solvents on cyp450-mediated metoprolol and imipramine metabolism in rat liver microsomes
